High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Warren Buffett handed the keys to Greg Abel and went quiet, leaving behind a $397 billion cash pile, a resumption of buybacks, and a stock sitting just below all-time highs. Five specific reasons explain why this transition moment could be the most compelling entry point in years.
Wall Street futures were given a new boost ahead of another packed earnings session, helped by a renewed fall in oil prices as hopes of a deal with Iran resurfaced. Dow Jones futures were up 453 points, or 0.9%, while those for the Nasdaq gained 0.9%. S&P 500 futures were 0.2% higher,...
BP posts a strong Q2 earnings surpass estimates as higher refining margins, hydrocarbon realizations and trading lift earnings and cash flow.
Caterpillar bulldozed Q2 earnings forecasts as the heavy equipment giant reported a $72 billion backlog, up 92% from a year ago. Long a global economic bellwether, Caterpillar has become a bellwether for the AI infrastructure boom amid soaring demand for its gas turbines to power data centers. The construction segment was Caterpillar's biggest growth driver in Q2, but growth was strong across the board.
Marathon Petroleum (MPC) delivered earnings and revenue surprises of +22.11% and +50.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Jamie Dimon said he sees both stocks and long-term bonds as expensive.
Warren Buffett's five biggest public bets have all moved sharply this year, but not in the same direction, and the gap between where he bought and where these stocks trade now tells a very different story for each one.
Zebra (ZBRA) delivered earnings and revenue surprises of +45.98% and +3.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Eli Lilly's key catalyst for 2027 could positively affect price action sooner than you think.
Efficiency leaders CLS, ZWS, LRCX, BESIY and JCI outperformed industry peers on key ratios, narrowing a 7,906-stock universe to just 18 picks.
Investing.com -- Wayfair shares slipped about 3% in premarket trading Tuesday despite the online furniture retailer posting second-quarter results ahead of expectations on both revenue and earnings.
Merck (MRK) delivered earnings and revenue surprises of +50.00% and +1.69%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
FIX, GS, VRT, STX and TRV are five momentum stocks for August as AI infrastructure, financial strength and earnings growth support their outlooks.
The drugmaker posted adjusted earnings of 77 cents per share and now expects full-year revenue of $60.5 billion to $62.5 billion
U.S. optical component stocks surged following a Reuters report that the Trump administration is drafting a ban on U.S. imports of new Chinese data center hardware. Applied Optoelectronics jumped 16%, Coherent gained 13%, Lumentum rose 11%, and Corning climbed 8%. According to four sources familiar with the matter, the Federal Communications Commission (FCC) is preparing restrictions against new Chinese optical transceivers—the critical hardware that routes data over fiber-optic cables inside AI
The tech giant has a significant stake in the space company.
ServiceNow stock has been cut nearly in half while its rivals panic over AI disruption, and one investor just put $20,000 on the line betting the market has it completely wrong.
The semiconductor materials supplier reported second-quarter earnings per share of $1.19 from sales of $1.4 billion. Wall Street was looking for EPS of $1.07 and sales of just under $1.4 billion.
Investing.com -- Caterpillar Inc. (NYSE: CAT) reported second-quarter results before the open on Tuesday, exceeding analyst expectations and sending its stock higher in premarket trading.
Investing.com -- Merck reported significantly better-than-expected earnings for the second quarter, while narrowing and raising its full-year revenue outlook.
Vertex Pharmaceuticals (NasdaqGS:VRTX) has agreed to acquire Crinetics Pharmaceuticals in a deal expected to close in the third quarter of 2026. The transaction is designed to broaden Vertex's reach in biotech and add new disease areas beyond its core cystic fibrosis franchise. Investors are watching for the potential impact on Vertex's drug pipeline and competitive position as the companies work toward closing. Vertex Pharmaceuticals enters this deal with a sizeable track record in cystic...
(Bloomberg) -- Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed for a split.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevApple’s New CEO Taps Retired Hardware Executive for Management TeamTaco Bell Met With Michigan on Parasite Weeks Before RecallMamdani Dismisses Business Leaders Advising NYC’s Mayor’s FundS&P 5
Aug 4 () - Pfizer on Tuesday slightly raised the lower end of its full-year revenue forecast after beating Wall Street estimates for second-quarter profit, driven by strong demand for blood thinner Eliquis. Pfizer is banking on newer medicines to offset fading COVID revenue and reduce reliance on aging blockbuster drugs, while investors look for signs that its $10 billion purchase of Metsera can help establish a meaningful presence in the fast-growing obesity market.
(Bloomberg) -- Caterpillar Inc. posted second-quarter earnings and revenue that beat Wall Street expectations as the company’s power-generation business continued to post strong growth off the back of data center spending.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevApple’s New CEO Taps Retired Hardware Executive for Management TeamTaco Bell Met With Michigan on Parasite Weeks Before RecallMamdani Dismisses Business Leaders Advising NYC’s Mayor’s FundS&P 500 C
September Nasdaq 100 E-Mini futures (NQU26) are up +0.67% this morning, signaling further gains for tech stocks as blockbuster earnings from Palantir Technologies boosted sentiment.
Several AI stocks are on sale.
Defense contractor Leidos (NYSE:LDOS) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.2% year on year to $4.56 billion. The company expects the full year’s revenue to be around $18.3 billion, close to analysts’ estimates. Its non-GAAP profit of $3.26 per share was 12.1% above analysts’ consensus estimates.
ON Semiconductor (NASDAQ:ON) shares climbed 7. 6% in pre-market trading after the chipmaker reported second-quarter 2026 results that exceeded Wall Street forecasts and issued a stronger-than-expected outlook for the current quarter.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
